Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11083752
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11084869
Antibody-mediated neutralization of Marburg virus
granted -
US 11086049
Anti-microbial bandage contact lens with ocular drug delivery
granted -
US 11085022
Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
granted -
US 11085057
Compositions and methods for modifying a target nucleic acid
granted -
US 11084884
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
granted -
US 11084872
Method for treating breast cancer
granted -
US 11084859
Targeted mutant interferon-gamma and uses thereof
granted -
US 11084856
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted -
US 11084844
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
granted -
US 11084809
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
granted -
US 11083850
Secure smart dosing system with automated delivery, measurement, and management
granted -
US 11084804
Modulators of ATP-binding cassette transporters
granted -
US 11083823
Tissue-separating fatty acid adhesion barrier
granted -
US 11084795
CFTR regulators and methods of use thereof
granted -
US 11083775
Transgenic corn with antifungal peptide AGM182 USDA (DN:0113.18)
granted -
US 11083794
Methods and compositions for self-regulated release of active pharmaceutical ingredient
granted -
US 11083788
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 11083797
Long-acting polymeric delivery systems
granted -
US 11083753
Targeted replacement of endogenous T cell receptors
granted -
US 11083730
Long-acting polymeric delivery systems
granted -
US 11083745
Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome
granted -
US 11083737
Methods of administering deflazacort therapy
granted -
US 11083708
Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.